pargyline has been researched along with Hallucinations in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paykel, ES | 1 |
1 other study available for pargyline and Hallucinations
| Article | Year |
|---|---|
Hallucinosis on combined methyldopa and pargyline.
Topics: Drug Synergism; Female; Hallucinations; Humans; Hypertension; Methyldopa; Middle Aged; Pargyline | 1966 |